Abstract:Extracellular matrix-degrading matrix metalloproteinase-1 (MMP-1) is one of the interstitial collagenases likely to be involved in tumor invasion and metastasis. MMP-1 may also contribute to tumor initiation and development by altering the cellular microenvironment that facilitates tumor formation. Recent studies have found that overexpression of MMP-1 is associated with the initial stages of cancer development in addition to promoting cellular invasion; however, preexisting oncogenic mutations or chemical carcinogens are required to initiate tumorigenesis as well. There is a single nucleotide polymorphism located in the promoter region of MMP-1 that partially regulates gene expression. The 2G/2G genotype enhances transcriptional activity and may be associated with an increased lung cancer risk. Using a case-control study, we tested the hypotheses that (a) individuals with the 2G/2G genotype may be at an increased risk for lung cancer; and (b) the risk should be greatly elevated in smoking individuals. PCR-RFLP was used to determine the MMP-1 genotypes in 456 lung-cancer cases and 451 frequency-matched controls of Caucasian ethnicity. Overall, there was a significant association between the 2G/2G genotype and lung cancer risk [odds ratio (OR), 1.76; 95% confidence interval (CI), 1.29–2.39]. In current smokers, the lung cancer risk associated with the 2G/2G genotype was significantly elevated (OR, 3 .16; 95% CI, 1.87–5.35). However, this association was less evident in former smokers (OR, 1.23; 95% CI, 0.81–1.87) and absent in never smokers (OR, 1.09; 95% CI, 0.31–3.91). Similarly, this risk was more evident in heavy smokers (OR, 2.55; 95% CI, 1.61–4.03) than in light smokers (OR, 1.40; 95% CI, 0.84–2.32). Interestingly, men were observed to have a 2.15-fold increased lung cancer risk (OR, 2.15; 95% CI, 1.42–3.26) compared with women (OR, 1.34; 95% CI, 0.84–2.15). Furthermore, subjects with 2G/2G genotype developed lung cancer earlier (60.94 0.64 years old) than patients with 1G/1G and 1G/2G genotypes (62.91 0.59 years old; P 0.024). Our data demonstrate that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers. To our knowledge, these results report the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.

DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large population.

Rapid genotyping of prostate cancer antigen 3 gene promoter polymorphism by denaturing high-performance liquid chromatography

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter is Associated with Colorectal Cancer.

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

Application of DHPLC in human genomic SNP screening and genotyping for all-trans-retinol dehydrogenase

No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Polymorphisms in the Promoter Regions of Matrix Metalloproteinases 1 and 3 and Cancer Risk: A Meta-Analysis of 50 Case-Control Studies

The Role of 1G/2G Polymorphism in MMP-1 Gene on Invasiveness of Gastric Cancer

Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan

Simultaneous Detection Of Cpg Methylation And Single Nucleotide Polymorphism By Denaturing High Performance Liquid Chromatography

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility 1

Meta-Analysis of Associations Between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases and the Risk of Colorectal Cancer

Polymorphisms in the MMP1 and MMP3 Promoter and Non-Small Cell Lung Carcinoma in North China.

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility.

High-throughput Screening of Prostate Cancer Risk Loci by Single Nucleotide Polymorphisms Sequencing.

Comprehensive Profiling of MDM2/TP53 Genomic Aberration in Chinese Patients with Diverse Malignancies.

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Correlation Between A Single Nucleotide Polymorphism In The Matrix Metalloproteinase-2 Promoter And Risk Of Lung Cancer

Genetic Polymorphism of Matrix Metalloproteinase-1 and Coronary Artery Disease Susceptibility: a Case-Control Study in a Han Chinese Population.